Stroke prevention and intervention: New options for improved outcomes

Postgraduate Medicine

Volumn 103, Issue 2, 1998, Pages 43-62

  Kelley, Roger E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; CAROTID ENDARTERECTOMY; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; EMBOLISM; FIBRINOLYTIC THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; RISK FACTOR; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

EID: 0031932528     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.02.353     Document Type: Review

References (40)

1. Delanty N, Vaughan CJ. Vascular effects of statins in stroke. Stroke 1997; 28(11):2315-20
2. Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325(18):1261-6
3. Sacco RL, Wolf PA, Kannel WB, et al. Survival and recurrence following stroke: the Framingham Study. Stroke 1982;13(3): 290-5
4. Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke 1988;19(8):937-41
5. Norris JW, Zhu CZ, Bornstein NM, et al. Vascular risks of asymptomatic carotid stenosis. Stroke 1991;22(12):1485-90
6. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA 1979; 242(23):2562-71
7. Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996;124(6): 548-56
8. Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335(14): 1001-9
9. Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): a randomized controlled trial. JAMA 1996;276(10):785-91
10. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347(9004):781-6
11. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308(6921): 81-106 [Erratum, BMJ 1994;308(6943): 1540]
12. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321(3):129-35
13. Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988;296(6618):313-6
14. Algra A, van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry 1996;60(2):197-9
15. Sivenius J, Laakso M, Penttila IM, et al. The European Stroke Prevention Study: results according to sex. Neurology 1991;41(8):1189-92
16. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143(1-2):1-13
17. Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321(8):501-7
18. Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;1(8649):1215-20
19. Weisberg LA. The efficacy and safety of ticlopidine and aspirin in non-whites: analysis of a patient subgroup from the Ticlopidine Aspirin Stroke Study. Neurology 1993;43(1):27-31
20. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348(9038): 1329-39
21. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990;322(12):863-8
22. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323(22): 1505-11
23. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343(8899):687-91
24. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348(9028):633-8
25. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342(8882):1255-62
26. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333(1):11-7
27. Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329(8):524-9
28. Azar AJ, Koudstaal PJ, Wintzen AR, et al. Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction. Ann Neurol 1996;39(3): 301-7
29. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332(15):993-7
30. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337(8752):1235-43
31. European Carotid Surgery Trialists' Collaborative Group. Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial. Lancet 1996;347(9015):1591-3
32. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273(18):1421-8
33. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333(24):1581-7
34. Jonas S. Anticoagulant therapy in cerebrovascular disease: review and metaanalysis. Stroke 1988;19(8):1043-8 [Erratum, Stroke 1989;20(4):562]
35. Yatsu FM, Hart RG, Mohr JP, et al. Anticoagulation of embolic strokes of cardiac origin: an update. Neurology 1988;38(2):314-6
36. Pessin MS, Estol CJ, Lafranchise F, et al. Safety of anticoagulation after hemorrhagic infarction. Neurology 1993;43(7):1298-303
37. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991;338(8767):597-600 [Erratum, Lancet 1991;338(8772):958]
38. Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology 1988;38(4):517-22
39. Glantz MJ, Burger PC, Friedman AH, et al. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 1994;44(11):2020-7
40. Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333(24):1588-93